(Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 13.00%-1.09M | -29.90%-2.02M | 66.02%-529.22K | -20.81%-5.51M | 36.86%-1.15M | -23.90%-1.25M | 3.93%-1.55M | -1,261.15%-1.56M | 0.85%-4.56M | -113.60%-1.82M |
Net income from continuing operations | 44.19%-1.27M | 18.47%-1.53M | 16.26%-1.75M | -25.16%-8.1M | 20.95%-1.86M | -58.55%-2.28M | -44.43%-1.87M | -51.13%-2.09M | 1.56%-6.47M | -19.47%-2.36M |
Operating gains losses | -157.27%-10.7K | -157.97%-16.67K | -583.19%-101.75K | 48.99%-155.94K | -380.96%-188.48K | 121.13%18.68K | 142.31%28.75K | 93.12%-14.89K | -148.68%-305.73K | -83.49%67.09K |
Depreciation and amortization | -2.52%49.19K | 6.18%54.35K | -7.99%50.61K | 22.71%213.53K | 10.39%56.87K | 22.96%50.47K | -26.34%51.18K | 359.92%55.01K | 295.47%174.01K | 356.57%51.52K |
Unrealized gains and losses of investment securities | -205.20%-121.83K | -95.26%1.57K | -97.80%3.86K | ---- | ---- | ---39.92K | --33.12K | --175.32K | ---- | ---- |
Remuneration paid in stock | -34.08%634.89K | -52.88%358.36K | -20.86%676.14K | 237.46%3.24M | 41.47%666.57K | 9,368.01%963.18K | 228.04%760.52K | 244.06%854.34K | -39.78%961.48K | 12.12%471.16K |
Other non cashItems | -301.36%-319.17K | -137.26%-276.59K | 81.94%-24.13K | ---- | ---- | ---79.52K | ---116.58K | ---133.65K | ---- | ---- |
Change In working capital | -1,332.37%-372.13K | -60.45%-886.64K | 208.65%588.53K | -217.32%-1.09M | 81.84%-22.08K | -92.99%30.2K | 4.24%-552.61K | -145.37%-541.66K | 265.81%925.8K | -148.60%-121.58K |
-Change in receivables | 100.44%652 | -34.70%64.43K | 120.24%21.22K | -815.29%-215.43K | -13.54%-60.76K | -268.07%-148.51K | 1,571.16%98.67K | -5,399.44%-104.82K | 233.17%30.12K | -1.74%-53.52K |
-Change in prepaid assets | 3.66%30.4K | 95.51%-14.49K | 72.80%-19.3K | -1,203.26%-306.66K | -81.95%58.1K | -80.29%29.32K | 40.84%-323.13K | -168.69%-70.96K | 108.17%27.8K | 296.22%321.93K |
-Change in payables and accrued expense | -369.89%-403.17K | -185.41%-936.58K | 260.33%586.62K | -164.99%-564.06K | 95.02%-19.42K | -22.74%149.38K | -1,257.33%-328.15K | -133.61%-365.87K | 543.52%867.89K | -183.54%-390K |
Interest received (cash flow from operating activities) | 301.36%319.17K | 137.25%276.59K | -81.94%24.13K | 143.31%370.1K | -41.34%40.36K | 160.72%79.52K | 366.81%116.58K | --133.64K | --152.11K | --68.8K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 13.00%-1.09M | -29.90%-2.02M | 66.02%-529.22K | -20.81%-5.51M | 36.86%-1.15M | -23.90%-1.25M | 3.93%-1.55M | -1,261.15%-1.56M | 0.85%-4.56M | -113.60%-1.82M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 87.70%-701.51K | 87.17%-788.22K | -32.31%-2.26M | -30.53%-17.03M | 16.40%-3.48M | -102.14%-5.7M | -109.79%-6.15M | 45.58%-1.71M | -174.12%-13.05M | -391.41%-4.16M |
Capital expenditure reported | 86.78%-688.37K | 86.40%-736.26K | 47.61%-2.14M | -62.46%-18.03M | 4.44%-3.32M | -124.63%-5.21M | -104.64%-5.41M | -53.60%-4.09M | -157.16%-11.1M | -238.13%-3.47M |
Net PPE purchase and sale | 86.08%-1.49K | 97.04%-1.79K | -102.17%-64.46K | 639.06%2.89M | 98.45%-2.01K | 95.52%-10.68K | -1,800.53%-60.44K | 1,891.31%2.97M | -380.31%-536.74K | -85.23%-129.65K |
Net other investing changes | 97.59%-11.66K | 92.53%-50.17K | 90.74%-54.3K | -34.14%-1.9M | 71.63%-157.83K | -81.83%-483.18K | -139.13%-671.43K | -87.58%-586.18K | -167.87%-1.42M | -1,816.56%-556.4K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 87.70%-701.51K | 87.17%-788.22K | -32.31%-2.26M | -30.53%-17.03M | 16.40%-3.48M | -102.14%-5.7M | -109.79%-6.15M | 45.58%-1.71M | -174.12%-13.05M | -391.41%-4.16M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | -69.34%71.63K | 91,005.61%24.51M | -53.72%825.12K | -34.22%320.13K | -35.21%244.47K | 9.56%233.61K | -96.19%26.9K | 65.67%1.78M | 64.43%486.69K |
Net common stock issuance | --0 | -69.34%71.63K | 91,005.61%24.51M | -53.72%825.12K | 69.54%825.12K | --0 | 9.56%233.61K | -96.19%26.9K | 65.67%1.78M | 64.43%486.69K |
Proceeds from stock option exercised by employees | --0 | ---- | ---- | ---- | ---- | --244.47K | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --0 | -69.34%71.63K | 91,005.61%24.51M | -53.72%825.12K | -34.22%320.13K | -35.21%244.47K | 9.56%233.61K | -96.19%26.9K | 65.67%1.78M | 64.43%486.69K |
Net cash flow | ||||||||||
Beginning cash position | 49.24%25.84M | 14.35%28.02M | -78.53%6.3M | -36.86%29.32M | -70.32%10.62M | -55.35%17.31M | -42.94%24.5M | -36.86%29.32M | 55.72%46.44M | -25.04%35.79M |
Current changes in cash | 73.29%-1.79M | 63.39%-2.73M | 770.42%21.72M | -37.22%-21.72M | 21.61%-4.31M | -94.22%-6.71M | -72.31%-7.46M | -27.09%-3.24M | -212.46%-15.83M | -291.50%-5.49M |
Effect of exchange rate changes | -2,700.38%-581.34K | 101.43%552.16K | 100.11%1.7K | -1.25%-1.31M | 97.68%-22.69K | -95.27%22.36K | 67.57%274.13K | -66.51%-1.58M | -150.77%-1.29M | -1,095.61%-977.25K |
End cash Position | 120.85%23.46M | 49.24%25.84M | 14.35%28.02M | -78.53%6.3M | -78.53%6.3M | -70.32%10.62M | -55.35%17.31M | -42.94%24.5M | -36.86%29.32M | -36.86%29.32M |
Free cash from | 72.48%-1.78M | 60.80%-2.75M | 50.49%-2.81M | -45.90%-23.63M | 17.61%-4.47M | -81.36%-6.47M | -64.77%-7.03M | -92.59%-5.67M | -79.36%-16.2M | -178.22%-5.42M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.